{"DataElement":{"publicId":"3923927","version":"1","preferredName":"Severe Aplastic Anemia Classification Type","preferredDefinition":"A description of severe aplastic anemia classification.","longName":"3923872v1.0:3923926v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"3923872","version":"1","preferredName":"Severe Aplastic Anemia Classification","preferredDefinition":"Life-threatening anemia associated with a high risk of infection or bleeding._A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"2594143v1.0:2321361v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"3945741","version":"1","preferredName":"Severe Aplastic Anemia","preferredDefinition":"Life-threatening anemia associated with a high risk of infection or bleeding.","longName":"C61229","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe Aplastic Anemia","conceptCode":"C61229","definition":"Life-threatening anemia associated with a high risk of infection or bleeding.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EA71D9CD-F510-F051-E040-BB89AD431A15","latestVersionIndicator":"Yes","beginDate":"2013-11-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-11-05","modifiedBy":"ONEDATA","dateModified":"2013-11-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2321361","version":"1","preferredName":"Classification","preferredDefinition":"Classification; the grouping of things into classes or categories.","longName":"C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCF89106-20AF-2D93-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-29","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-29","modifiedBy":"ONEDATA","dateModified":"2005-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9062A8B-E713-DD00-E040-BB89AD437711","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3923926","version":"1","preferredName":"Severe Aplastic Anemia Type","preferredDefinition":"Life-threatening anemia associated with a high risk of infection or bleeding._Something distinguishable as an identifiable class based on common qualities.","longName":"3923926v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Dyskeratosis congenita","valueDescription":"Dyskeratosis Congenita","ValueMeaning":{"publicId":"3940911","version":"1","preferredName":"Dyskeratosis Congenita","longName":"3940911","preferredDefinition":"A rare genetic disorder characterized by nail dystrophy, reticulated skin pigmentation especially on the neck and chest, and oral leukoplakia.  In about half the cases mutations in the TERT, TERC, DKC1, or TINF2 genes are identified.  Patients are at an increased risk of developing bone marrow failure, myelodysplastic syndrome, leukemia, or cancer, especially in the head and neck region.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dyskeratosis Congenita","conceptCode":"C111802","definition":"A rare genetic disorder characterized by nail dystrophy, reticulated skin pigmentation especially on the neck and chest, and oral leukoplakia.  In about half the cases mutations in the TERT, TERC, DKC1, or TINF2 genes are identified.  Patients are at an increased risk of developing bone marrow failure, myelodysplastic syndrome, leukemia, or cancer, especially in the head and neck region.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EA08B251-5C80-ED4B-E040-BB89AD4371A4","latestVersionIndicator":"Yes","beginDate":"2013-10-31","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EA08B251-5C99-ED4B-E040-BB89AD4371A4","beginDate":"2013-10-31","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-31","modifiedBy":"ONEDATA","dateModified":"2013-10-31","deletedIndicator":"No"},{"value":"Acquired severe aplastic anemia, not otherwise specified","valueDescription":"Acquired Severe Aplastic Anemia Not Otherwise Specified","ValueMeaning":{"publicId":"3923941","version":"1","preferredName":"Acquired Severe Aplastic Anemia Not Otherwise Specified","longName":"3923941","preferredDefinition":"Of or relating to a medical condition or characteristic that is not present at birth and develops subsequently.: Life-threatening anemia associated with a high risk of infection or bleeding.: Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acquired","conceptCode":"C85869","definition":"Of or relating to a medical condition or characteristic that is not present at birth but develops subsequently.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Severe Aplastic Anemia","conceptCode":"C61229","definition":"Life-threatening anemia associated with a high risk of infection or bleeding.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E907184B-65DF-D39A-E040-BB89AD431AF5","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E907184B-65F8-D39A-E040-BB89AD431AF5","beginDate":"2013-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-18","modifiedBy":"ONEDATA","dateModified":"2013-10-18","deletedIndicator":"No"},{"value":"Acquired SAA secondary to toxin / other drug","valueDescription":"Acquired Drug-Induced Aplastic Anemia","ValueMeaning":{"publicId":"3923939","version":"1","preferredName":"Acquired Drug-Induced Aplastic Anemia","longName":"3923939","preferredDefinition":"Of or relating to a medical condition or characteristic that is not present at birth and develops subsequently.: A state of bone marrow suppression and failure that is caused by a cytotoxic or adverse immunologic response to a drug treatment, leading to a failure of production of red blood cells, white cells and platelets.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acquired","conceptCode":"C85869","definition":"Of or relating to a medical condition or characteristic that is not present at birth but develops subsequently.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Drug-Induced Aplastic Anemia","conceptCode":"C35343","definition":"A state of bone marrow suppression and failure that is caused by a cytotoxic or adverse immunologic response to a drug treatment, leading to a failure of production of red blood cells, white cells and platelets.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E907184B-6592-D39A-E040-BB89AD431AF5","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E907184B-65AB-D39A-E040-BB89AD431AF5","beginDate":"2013-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-18","modifiedBy":"ONEDATA","dateModified":"2013-10-18","deletedIndicator":"No"},{"value":"Acquired SAA secondary to hepatitis","valueDescription":"Acquired Aplastic Anemia due to Hepatitis","ValueMeaning":{"publicId":"3923940","version":"1","preferredName":"Acquired Aplastic Anemia due to Hepatitis","longName":"3923940","preferredDefinition":"Of or relating to a medical condition or characteristic that is not present at birth and develops subsequently.: Bone marrow failure defined as pancytopenia, secondary to hepatitis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acquired","conceptCode":"C85869","definition":"Of or relating to a medical condition or characteristic that is not present at birth but develops subsequently.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Aplastic Anemia due to Hepatitis","conceptCode":"C61231","definition":"Bone marrow failure defined as pancytopenia, secondary to hepatitis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E907184B-65B8-D39A-E040-BB89AD431AF5","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E907184B-65D1-D39A-E040-BB89AD431AF5","beginDate":"2013-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-18","modifiedBy":"ONEDATA","dateModified":"2013-10-18","deletedIndicator":"No"},{"value":"Acquired amegakaryocytosis (not congenital)","valueDescription":"Acquired Amegakaryocytosis","ValueMeaning":{"publicId":"3923942","version":"1","preferredName":"Acquired Amegakaryocytosis","longName":"3923942","preferredDefinition":"Of or relating to a medical condition or characteristic that is not present at birth and develops subsequently.: A non-neoplastic, congenital or non-congenital disorder charcaterized by marked reduction or absence of megakaryocytes and thrombocytopenia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acquired","conceptCode":"C85869","definition":"Of or relating to a medical condition or characteristic that is not present at birth but develops subsequently.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Amegakaryocytosis","conceptCode":"C61248","definition":"A non-neoplastic, congenital or non-congenital disorder charcaterized by marked reduction or absence of megakaryocytes and thrombocytopenia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E907184B-6605-D39A-E040-BB89AD431AF5","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E907184B-661E-D39A-E040-BB89AD431AF5","beginDate":"2007-10-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-18","modifiedBy":"ONEDATA","dateModified":"2013-10-18","deletedIndicator":"No"},{"value":"Other acquired cytopenic syndrome","valueDescription":"Other Acquired Cytopenia","ValueMeaning":{"publicId":"3923943","version":"1","preferredName":"Other Acquired Cytopenia","longName":"3923943","preferredDefinition":"Different than the one(s) previously specified or mentioned.: Of or relating to a medical condition or characteristic that is not present at birth and develops subsequently.: A reduction in the number of blood cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Acquired","conceptCode":"C85869","definition":"Of or relating to a medical condition or characteristic that is not present at birth but develops subsequently.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cytopenia","conceptCode":"C2979","definition":"A laboratory test result indicating an abnormally low quantity of circulating blood cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E907184B-662C-D39A-E040-BB89AD431AF5","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E907184B-6645-D39A-E040-BB89AD431AF5","beginDate":"2007-10-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-18","modifiedBy":"ONEDATA","dateModified":"2013-10-18","deletedIndicator":"No"},{"value":"Acquired pure red cell aplasia (not congenital)","valueDescription":"Acquired Pure Red Cell Aplasia","ValueMeaning":{"publicId":"3322381","version":"1","preferredName":"Acquired Pure Red Cell Aplasia","longName":"3322381","preferredDefinition":"A disease characterized by normocytic, normochromic anemia, low hematocrit, reticulocytopenia and selective erythroid hypoplasia. It can occur as a chronic or acute form; the former is predominantly seen in adults and the latter in children.  Pathogenesis involves immune dysfunction with antibodies directed against erythroid precursor cells or erythropoietin, or due to T-cell mediated suppression of erythropoiesis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acquired Pure Red Cell Aplasia","conceptCode":"C70548","definition":"A disease characterized by normocytic, normochromic anemia, low hematocrit, reticulocytopenia and selective erythroid hypoplasia. It can occur as a chronic or acute form; the former is predominantly seen in adults and the latter in children. Pathogenesis involves immune dysfunction with antibodies directed against erythroid precursor cells or erythropoietin, or due to T-cell mediated suppression of erythropoiesis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B36DFA8A-BB14-6AE7-E040-BB89AD432073","latestVersionIndicator":"Yes","beginDate":"2011-12-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-12-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E97F8ACE-7263-89EB-E040-BB89AD436F63","beginDate":"2007-10-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-24","modifiedBy":"ONEDATA","dateModified":"2013-10-24","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3923925","version":"1","preferredName":"Severe Aplastic Anemia Type","preferredDefinition":"Life-threatening anemia associated with a high risk of infection or bleeding.:Something distinguishable as an identifiable class based on common qualities.","longName":"C61229:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe Aplastic Anemia","conceptCode":"C61229","definition":"Life-threatening anemia associated with a high risk of infection or bleeding.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E90685B1-3334-0864-E040-BB89AD43216D","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-18","modifiedBy":"ONEDATA","dateModified":"2013-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E90685B1-3345-0864-E040-BB89AD43216D","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-18","modifiedBy":"KUMMEROA","dateModified":"2014-01-08","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685478","version":"1","longName":"Testing Set â€“ Moderately Different","context":"NCIP"}]}],"AlternateNames":[{"name":"PreTed_prime_dis_hct_saa_class","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_ICT_saa_class","type":"NMDP_FN","context":"NHLBI"},{"name":"TDIS_SAA_saa_class","type":"NMDP_FN","context":"NHLBI"},{"name":"PerformedDiagnosis:value","type":"HCT_BRIDG_5","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the classification o","type":"Preferred Question Text","description":"What was the classification of severe aplastic anemia?","url":null,"context":"NHLBI"},{"name":"Specify the severe aplastic anemia classification","type":"Alternate Question Text","description":"Specify the severe aplastic anemia classification","url":null,"context":"NHLBI"},{"name":"Specify the severe aplastic anemia classification","type":"Application Standard Question Text","description":"Specify the severe aplastic anemia classification","url":null,"context":"NHLBI"},{"name":"Specify severe aplastic anemia classification","type":"Alternate Question Text","description":"Specify severe aplastic anemia classification","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E90685B1-3398-0864-E040-BB89AD43216D","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-18","modifiedBy":"ALEYR","dateModified":"2019-04-13","changeDescription":". Added human readable def. System generated def displayed as alt def. No version needed. AK 11/17/14. 4/15/16mn-added aqt.; Added HCT_BRIDG5 alternate name - RR 2018-12-23","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}